GAIRING, Simon J., RÖHLEN, Natascha, BETTINGER, Dominik und FOERSTER, Friedrich, 2025. Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab. Freiburg: Universität.
Elsevier - Harvard (with titles)Gairing, S.J., Röhlen, N., Bettinger, D., Foerster, F., 2025. Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab. Universität, Freiburg. https://doi.org/10.1016/j.jhepr.2024.101295
American Psychological Association 7th editionGairing, S. J., Röhlen, N., Bettinger, D., & Foerster, F. (ca. 2025). Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab [Cd]. Universität. https://doi.org/10.1016/j.jhepr.2024.101295
Springer - Basic (author-date)Gairing SJ, Röhlen N, Bettinger D, Foerster F (2025) Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Gairing, Simon J./ Röhlen, Natascha/ Bettinger, Dominik/ Foerster, Friedrich, Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab, Freiburg 2025.